Wednesday, December 23, 2020
LSBio (LSBio ™), a leading provider of antibodies and reagents for life science research, is pleased to announce the acquisition of Absolute Antibody, Ltd., based in Redcar, United Kingdom, and the subsidiary Kerafast. The terms of the transaction were not disclosed.
LSBio provides IHC validated antibodies / reagents and services to the global community of academic, pharmaceutical and biotech researchers. The Company has created a catalog of over 750,000 antibodies / reagents, assay kits, proteins and biochemicals and, with the acquisition of Absolute Antibody and Kerafast, further expands its product portfolio by adding a range of unique reagents and services in antibody segment.
Absolute Antibody is a specialist in antibody recombination technology and offers customized services for antibody sequencing, engineering and manufacturing of recombinants, as well as a unique catalog of antibodies / recombinants and Fc fusion proteins, engineered in new formats useful.
The original text of this announcement, written in the source language, is the authentic official version. Translations are offered solely for the convenience of the reader and must refer to the original text, which is the only legally valid text.
